|
A Model for Responding to Chemotherapy Infusion Hypersensitivity Reactions |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Acute Myeloid Leukemia: Role of FLT3 Inhibitors After Allogeneic Hematopoietic Cell Transplantation |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Advances in the Management of Metastatic Breast Cancer with SABCS Updates |
1.00 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
|
Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Amyloidosis: Diagnosis, Treatment, and Supportive Care |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates |
2.00 |
12/20/2024 - 12:00am to 12/20/2025 - 12:00am |
|
Applying NCCN Guidelines for the Treatment of CLL/SLL in Clinical Practice: The Right Agent for the Right Patient at the Right Time |
1.50 |
07/23/2024 - 12:00am to 07/23/2025 - 12:00am |
|
Appropriate Vaccinations for Patients in Survivorship |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas |
1.00 |
06/05/2024 - 12:00am to 06/05/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Management of Early-Stage Non-Small Cell Lung Cancer |
1.00 |
02/27/2024 - 12:00am to 02/27/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma |
1.00 |
05/17/2024 - 12:00am to 05/17/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Sequencing Therapies for Patients with Metastatic HER2-Negative Breast Cancer |
1.00 |
03/06/2024 - 12:00am to 03/06/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer |
1.00 |
05/02/2024 - 12:00am to 05/02/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia |
1.00 |
05/29/2024 - 12:00am to 05/29/2025 - 12:00am |
|
Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer |
1.00 |
10/28/2024 - 12:00am to 10/28/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward